Delivery Order HHSN268201600011I-HHSN2680002
Award Date
7/10/17
Potential Completion Date
7/9/19
Potential Value
$1.7M
Federal Agency
National Heart Lung and Blood Institute
Ultimate Awardee
Not listed
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Irwindale, CA 91010, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This delivery order for $662,778.28 was awarded against the Production Assistance for Cellular Therapies - Cell Processing Facilities (PACT-CPF) master IDIQ by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute to Beckman Research Institute Of The City Of Hope, a nonprofit organization located in Irwindale, California. The order is for cell manufacturing and process development services for research stem cell-derived cardiomyocyte...
This is a $872,250.00 firm fixed-price delivery order awarded by the National Heart Lung and Blood Institute, a civilian agency, to Beckman Research Institute of the City of Hope, a nonprofit organization. The order is under the Production Assistance for Cellular Therapies (PACT) - Cell Processing Facilities (PACT-CPF) indefinite delivery, indefinite quantity (IDIQ) contract. The contract is for production assistance services related to cellular therapies. There was no set-aside designation....
This federal contract award is for PRODUCTION ASSISTANCE FOR CELLULAR THERAPIES (PACT)- CELL PROCESSING FACILITIES CELL-TASK AREA 2, PCT0050-01: HESC-DERIVED CARDIOMYOCYTE PROGENITOR CELLS FOR PRECLINICAL ANIMAL STUDIES. The contract, with a potential value of $211,854.50, was awarded on October 20, 2020 by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Heart Lung and Blood Institute to Beckman Research Institute of the City of Hope, a non-profit...
This is a delivery order awarded by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute to Beckman Research Institute Of The City Of Hope, a nonprofit organization, for PRODUCTION ASSISTANCE FOR CELLULAR THERAPIES (PACT) - CELL PROCESSING FACILITIES services. The $1,493,579.31 delivery order is part of the larger PACT-CPF indefinite delivery/indefinite quantity (IDIQ) contract. The delivery order does not have a set-aside designation....
This is a federal contract award to Beckman Research Institute of the City of Hope, a nonprofit organization, to provide cell manufacturing and process development services for regenerative cell therapies. The contract was awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), under the Production Assistance for Cellular Therapies - Cell Processing Facilities (PACT-CPF) indefinite delivery, indefinite quantity (IDIQ) contract...
The National Heart Lung and Blood Institute (NHLBI) awarded a $7,334,044.67 cost-reimbursement contract to Beckman Research Institute of the City of Hope, a nonprofit organization, to provide support for the Production Assistance for Cellular Therapies (PACT) Program's cell processing facilities. This contract, which has no set-aside designation, will assist with the production and development of cellular therapies through May 2018. The PACT Program aims to advance cellular therapy research...
This is a $1,405,000.00 firm fixed price purchase order contract awarded by the National Human Genome Research Institute, a component of the Department of Health and Human Services, to the New York Stem Cell Foundation Inc., a non-profit organization. The contract is for services related to beta cell differentiation and cell assays, which aligns with the original solicitation that sought the development of assays to evaluate the differentiation of stem cells into insulin-producing beta cells. No...
This is a federal contract award to Wicell Research Institute, Inc., a non-profit organization, by the National Heart Lung and Blood Institute, a component of the U.S. Department of Health and Human Services. The contract, valued at $16,137,048.00, is for the provision of human pluripotent stem cell lines, testing, and related services to support biomedical research. Wicell is a global leader in stem cell banking and distribution, and has provided specific cell lines to the National Institutes...
This is a federal contract award from the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Xcell Science Incorporated, a minority-owned, woman-owned small business. The contract has an award value of $1,001,068.00 and a period of performance ending on February 28, 2014. It is a delivery order under the larger "Gene Insertion - Pluripotent Stem Cells 2012-2017" indefinite-delivery, indefinite-quantity (IDIQ) contract. The contract is for professional support...
This $238,000.00 firm-fixed price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to the New York Stem Cell Foundation, Inc., a non-profit organization that conducts stem cell research. The contract is for the derivation of induced pluripotent stem cells, which aligns with the foundation's work in generating stem cell lines, differentiating them into various cell types, and...